At this time, StocksHaven Investments would like to recall and look back at the last few months of equity advice in order to showcase the proven track record. The following is a list of chosen companies which have been nothing short of stellar, giving investors much needed short term and long term gains despite the ongoing hostile recessionary environment.
1. Spongetech Delivery Systems, Inc. (+948% as of April/1/09) [ Article Link ]
2. Mesa Air Group, Inc. (+75% as of April/24/09) [ Article Link ]
3. Hemispherx Biopharma, Inc. (+ 52% as of May/8/09) [ Article Link ]
4. Access Pharmaceuticals (+57% as of June/10/09) [ Article Link ]
5. Nephros, Inc. (+58.4% as of June/17/09) [ Article Link ]
6. Bioelectronics Corp. (+1913% as of June/19/09) [ Article Link ]
7. TerreStar Corporation (+44% as of July/9/09) [ Article Link]
8. Hard to Treat Diseases, Inc. (+1045% as of July/21/09) [ Article Link ]
9. Somaxon Pharmaceuticals, Inc. (+67.26% as of July/22/09) [ Article Link ]
10. SymPowerco Corp. (+157.14% as of July/29/09) [ Article Link ]
Recent news on our latest pick, (PINK:SYMW)
Tom Bustamante, the Managing Partner of Ludlow Capital Research commented, “With the recent announcement of Chevy’s electric Volt the demand for alternative electric vehicles has been gaining strong interest. On the small cap side, SymPowerco’s subsidiaries, HOSS Motor Sports and Highline Hydrogen Hybrids Systems, should offer operating holding corps for joint ventures and development of electric motor car solutions.”
“The stock is considered highly speculative, but seems to be attracting increasing attention from the market. Technically the stock has been generating increasing strong retail volume, and looks to be making an attempt to move above their longer-term trend line moving average. Again, it may be a very small speculative micro-cap play, but on mere momentum we wouldn’t be surprised to see this company push up above the $0.01 mark in the very near-term.”
Technical Analysis
According to StockTA.com, short, medium, and long term indicators display the largest level of BUY RATING near the 100% level. Resistance is set to 0.0025 which should be tested within the coming days. Any new company PRs regarding the acquisition process of the new subsidiaries, and or an update on the facility in Dumas, Arkinsas, and you can expect the price per share to easily surpass the 0.0030 level.
—
By reading StocksHaven Investments you agree to the disclaimer, and thereby will not hold Michael Vlaicu accountable for any transactions or decisions you make. It is up to you to do your own due diligence.
Wow that’s quite a good record, it would be nice if you included the losers as well though. I’m sure there’s at least a couple.
yea like EESO, any idea if that is still good? I am holding it still. It dropped like 10X below the price I bought.
Win some Lose some fellows – are you not investors/traders? Even God rested on the 7th day. Take your gains AND your losses equally…GLTYou
Yeah that was my point nypharm.. there should be equal gains and losses, he only included gains.